Proactiveinvestors Australia Faron Pharmaceuticals Ltd https://www.proactiveinvestors.com.au Proactiveinvestors Australia Faron Pharmaceuticals Ltd RSS feed en Sun, 17 Nov 2019 21:48:02 +1100 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) Small cap movers: Faron Pharma rockets as its rakes in more funds to bankroll new cancer drug https://www.proactiveinvestors.com.au/companies/news/906657/small-cap-movers-faron-pharma-rockets-as-its-rakes-in-more-funds-to-bankroll-new-cancer-drug-906657.html Sat, 09 Nov 2019 10:00:00 +1100 https://www.proactiveinvestors.com.au/companies/news/906657/small-cap-movers-faron-pharma-rockets-as-its-rakes-in-more-funds-to-bankroll-new-cancer-drug-906657.html Faron Pharma cash injection will fund development of cancer drug https://www.proactiveinvestors.com.au/companies/news/906612/faron-pharma-cash-injection-will-fund-development-of-cancer-drug-906612.html Fri, 08 Nov 2019 07:38:00 +1100 https://www.proactiveinvestors.com.au/companies/news/906612/faron-pharma-cash-injection-will-fund-development-of-cancer-drug-906612.html Faron confirms no known reason for share price surge https://www.proactiveinvestors.com.au/companies/news/906146/faron-confirms-no-known-reason-for-share-price-surge-906146.html Fri, 01 Nov 2019 14:39:00 +1100 https://www.proactiveinvestors.com.au/companies/news/906146/faron-confirms-no-known-reason-for-share-price-surge-906146.html Faron Pharma “extremely happy” with progress of Clevegen trial https://www.proactiveinvestors.com.au/companies/news/904452/faron-pharma-extremely-happy-with-progress-of-clevegen-trial-904452.html Wed, 16 Oct 2019 15:07:00 +1100 https://www.proactiveinvestors.com.au/companies/news/904452/faron-pharma-extremely-happy-with-progress-of-clevegen-trial-904452.html 'Immune activation from Clevegen has now been demonstrated' Faron Pharma CEO https://www.proactiveinvestors.com.au/companies/news/904931/-immune-activation-from-clevegen-has-now-been-demonstrated---faron-pharma-ceo-904931.html Wed, 16 Oct 2019 08:10:00 +1100 https://www.proactiveinvestors.com.au/companies/news/904931/-immune-activation-from-clevegen-has-now-been-demonstrated---faron-pharma-ceo-904931.html Faron Pharmaceuticals makes good progress with Clevegen immunotherapy trial https://www.proactiveinvestors.com.au/companies/news/215244/faron-pharmaceuticals-makes-good-progress-with-clevegen-immunotherapy-trial-215244.html Wed, 09 Oct 2019 14:57:00 +1100 https://www.proactiveinvestors.com.au/companies/news/215244/faron-pharmaceuticals-makes-good-progress-with-clevegen-immunotherapy-trial-215244.html Faron explores options for drug ingredients manufacturing https://www.proactiveinvestors.com.au/companies/news/903995/faron-explores-options-for-drug-ingredients-manufacturing-903995.html Wed, 02 Oct 2019 11:16:00 +1000 https://www.proactiveinvestors.com.au/companies/news/903995/faron-explores-options-for-drug-ingredients-manufacturing-903995.html Faron Pharma in talks to find partner for lead cancer drug https://www.proactiveinvestors.com.au/companies/news/903209/faron-pharma-in-talks-to-find-partner-for-lead-cancer-drug-903209.html Mon, 23 Sep 2019 06:50:00 +1000 https://www.proactiveinvestors.com.au/companies/news/903209/faron-pharma-in-talks-to-find-partner-for-lead-cancer-drug-903209.html Faron Pharma cancer drug to be focus of poster presentation at leading industry conference https://www.proactiveinvestors.com.au/companies/news/901840/faron-pharma-cancer-drug-to-be-focus-of-poster-presentation-at-leading-industry-conference-901840.html Mon, 02 Sep 2019 06:54:00 +1000 https://www.proactiveinvestors.com.au/companies/news/901840/faron-pharma-cancer-drug-to-be-focus-of-poster-presentation-at-leading-industry-conference-901840.html Faron Pharma fundraiser brings in £2.3mln https://www.proactiveinvestors.com.au/companies/news/901516/faron-pharma-fundraiser-brings-in-23mln-901516.html Tue, 27 Aug 2019 06:13:00 +1000 https://www.proactiveinvestors.com.au/companies/news/901516/faron-pharma-fundraiser-brings-in-23mln-901516.html Faron Pharmaceuticals bags first part of £2.8mln fundraising https://www.proactiveinvestors.com.au/companies/news/900225/faron-pharmaceuticals-bags-first-part-of-28mln-fundraising-900225.html Tue, 06 Aug 2019 14:11:00 +1000 https://www.proactiveinvestors.com.au/companies/news/900225/faron-pharmaceuticals-bags-first-part-of-28mln-fundraising-900225.html Faron Pharma plans to raise up to £2.8mln to fund cancer drug development https://www.proactiveinvestors.com.au/companies/news/900096/faron-pharma-plans-to-raise-up-to-28mln-to-fund-cancer-drug-development-900096.html Mon, 05 Aug 2019 06:53:00 +1000 https://www.proactiveinvestors.com.au/companies/news/900096/faron-pharma-plans-to-raise-up-to-28mln-to-fund-cancer-drug-development-900096.html Faron Pharma set to expand Clevegen cancer trial as data continues to impress https://www.proactiveinvestors.com.au/companies/news/314138/faron-pharma-set-to-expand-clevegen-cancer-trial-as-data-continues-to-impress-14138.html Thu, 18 Jul 2019 14:38:00 +1000 https://www.proactiveinvestors.com.au/companies/news/314138/faron-pharma-set-to-expand-clevegen-cancer-trial-as-data-continues-to-impress-14138.html Faron Pharma chief "thrilled" at early cancer trial progress https://www.proactiveinvestors.com.au/companies/news/223805/faron-pharma-chief--thrilled--at-early-cancer-trial-progress-223805.html Fri, 12 Jul 2019 08:15:00 +1000 https://www.proactiveinvestors.com.au/companies/news/223805/faron-pharma-chief--thrilled--at-early-cancer-trial-progress-223805.html Faron says interim analysis supports continuation of INFORAAA trial https://www.proactiveinvestors.com.au/companies/news/222827/faron-says-interim-analysis-supports-continuation-of-inforaaa-trial-222827.html Wed, 26 Jun 2019 06:43:00 +1000 https://www.proactiveinvestors.com.au/companies/news/222827/faron-says-interim-analysis-supports-continuation-of-inforaaa-trial-222827.html Faron getting to the bottom of the Traumakine conundrum https://www.proactiveinvestors.com.au/companies/news/222125/faron-getting-to-the-bottom-of-the-traumakine-conundrum-222125.html Fri, 14 Jun 2019 06:46:00 +1000 https://www.proactiveinvestors.com.au/companies/news/222125/faron-getting-to-the-bottom-of-the-traumakine-conundrum-222125.html Faron Pharmaceuticals - Proactive One2One Investor Forum May 2019 https://www.proactiveinvestors.com.au/companies/news/313485/faron-pharmaceuticals---proactive-one2one-investor-forum-may-2019-13485.html Fri, 24 May 2019 14:37:00 +1000 https://www.proactiveinvestors.com.au/companies/news/313485/faron-pharmaceuticals---proactive-one2one-investor-forum-may-2019-13485.html Faron Pharma finance boss to transition into new role next month https://www.proactiveinvestors.com.au/companies/news/220927/faron-pharma-finance-boss-to-transition-into-new-role-next-month-220927.html Fri, 24 May 2019 09:25:00 +1000 https://www.proactiveinvestors.com.au/companies/news/220927/faron-pharma-finance-boss-to-transition-into-new-role-next-month-220927.html Faron Pharma raises around €1.34mln from share subscription by existing shareholder https://www.proactiveinvestors.com.au/companies/news/220195/faron-pharma-raises-around-134mln-from-share-subscription-by-existing-shareholder-220195.html Tue, 14 May 2019 07:17:00 +1000 https://www.proactiveinvestors.com.au/companies/news/220195/faron-pharma-raises-around-134mln-from-share-subscription-by-existing-shareholder-220195.html Faron Pharma gears up for “pivotal year”; bosses convinced by Traumakine’s potential https://www.proactiveinvestors.com.au/companies/news/219770/faron-pharma-gears-up-for-pivotal-year-bosses-convinced-by-traumakines-potential-219770.html Tue, 07 May 2019 14:00:00 +1000 https://www.proactiveinvestors.com.au/companies/news/219770/faron-pharma-gears-up-for-pivotal-year-bosses-convinced-by-traumakines-potential-219770.html Faron Pharma updates on Clevegen development as partner discussions advance https://www.proactiveinvestors.com.au/companies/news/313238/faron-pharma-updates-on-clevegen-development-as-partner-discussions-advance-13238.html Tue, 07 May 2019 12:17:00 +1000 https://www.proactiveinvestors.com.au/companies/news/313238/faron-pharma-updates-on-clevegen-development-as-partner-discussions-advance-13238.html Faron Pharma: Japanese data bears out earlier study result https://www.proactiveinvestors.com.au/companies/news/219236/faron-pharma-japanese-data-bears-out-earlier-study-result-219236.html Mon, 29 Apr 2019 06:58:00 +1000 https://www.proactiveinvestors.com.au/companies/news/219236/faron-pharma-japanese-data-bears-out-earlier-study-result-219236.html Faron Pharma to expand its Clevegen trial to focus on Colorectal cancer https://www.proactiveinvestors.com.au/companies/news/312963/faron-pharma-to-expand-its-clevegen-trial-to-focus-on-colorectal-cancer-12963.html Thu, 11 Apr 2019 11:15:00 +1000 https://www.proactiveinvestors.com.au/companies/news/312963/faron-pharma-to-expand-its-clevegen-trial-to-focus-on-colorectal-cancer-12963.html Faron to target colorectal cancer patients in ongoing Clevegen study after early promise https://www.proactiveinvestors.com.au/companies/news/218391/faron-to-target-colorectal-cancer-patients-in-ongoing-clevegen-study-after-early-promise-218391.html Thu, 11 Apr 2019 06:55:00 +1000 https://www.proactiveinvestors.com.au/companies/news/218391/faron-to-target-colorectal-cancer-patients-in-ongoing-clevegen-study-after-early-promise-218391.html Faron Pharma up on cancer trial positive as it raises €3.12mln to advance development programmes https://www.proactiveinvestors.com.au/companies/news/217197/faron-pharma-up-on-cancer-trial-positive-as-it-raises-312mln-to-advance-development-programmes-217197.html Tue, 26 Mar 2019 15:50:00 +1100 https://www.proactiveinvestors.com.au/companies/news/217197/faron-pharma-up-on-cancer-trial-positive-as-it-raises-312mln-to-advance-development-programmes-217197.html Faron Pharma chief executive says Clevegen results suggest it can be a new tool against cancer https://www.proactiveinvestors.com.au/companies/news/215075/faron-pharma-chief-executive-says-clevegen-results-suggest-it-can-be-a-new-tool-against-cancer-215075.html Thu, 21 Feb 2019 15:48:00 +1100 https://www.proactiveinvestors.com.au/companies/news/215075/faron-pharma-chief-executive-says-clevegen-results-suggest-it-can-be-a-new-tool-against-cancer-215075.html Faron Pharma makes encouraging start in Clevegen solid tumour trial https://www.proactiveinvestors.com.au/companies/news/312313/faron-pharma-makes-encouraging-start-in-clevegen-solid-tumour-trial-12313.html Thu, 21 Feb 2019 14:06:00 +1100 https://www.proactiveinvestors.com.au/companies/news/312313/faron-pharma-makes-encouraging-start-in-clevegen-solid-tumour-trial-12313.html Faron Pharma makes encouraging start in Clevegen solid tumour trial https://www.proactiveinvestors.com.au/companies/news/215021/faron-pharma-makes-encouraging-start-in-clevegen-solid-tumour-trial-215021.html Thu, 21 Feb 2019 07:59:00 +1100 https://www.proactiveinvestors.com.au/companies/news/215021/faron-pharma-makes-encouraging-start-in-clevegen-solid-tumour-trial-215021.html Study shows cancer-fighting potential of anti-Clever-1 antibodies such as Faron Pharma’s Clevegen https://www.proactiveinvestors.com.au/companies/news/214537/study-shows-cancer-fighting-potential-of-anti-clever-1-antibodies-such-as-faron-pharmas-clevegen-214537.html Wed, 13 Feb 2019 11:00:00 +1100 https://www.proactiveinvestors.com.au/companies/news/214537/study-shows-cancer-fighting-potential-of-anti-clever-1-antibodies-such-as-faron-pharmas-clevegen-214537.html Faron Pharmaceuticals provides insight on phase III trial https://www.proactiveinvestors.com.au/companies/news/311679/faron-pharmaceuticals-provides-insight-on-phase-iii-trial-11679.html Thu, 20 Dec 2018 10:31:00 +1100 https://www.proactiveinvestors.com.au/companies/news/311679/faron-pharmaceuticals-provides-insight-on-phase-iii-trial-11679.html Faron Pharmaceuticals provides insight on phase III trial https://www.proactiveinvestors.com.au/companies/news/211463/faron-pharmaceuticals-provides-insight-on-phase-iii-trial-211463.html Wed, 19 Dec 2018 10:05:00 +1100 https://www.proactiveinvestors.com.au/companies/news/211463/faron-pharmaceuticals-provides-insight-on-phase-iii-trial-211463.html Faron Pharmaceuticals says first patient successfully been dosed in the phase I/II MATINS study of Clevegen https://www.proactiveinvestors.com.au/companies/news/211230/faron-pharmaceuticals-says-first-patient-successfully-been-dosed-in-the-phase-iii-matins-study-of-clevegen-211230.html Fri, 14 Dec 2018 11:37:00 +1100 https://www.proactiveinvestors.com.au/companies/news/211230/faron-pharmaceuticals-says-first-patient-successfully-been-dosed-in-the-phase-iii-matins-study-of-clevegen-211230.html Faron Pharma confident Traumakine could be ‘very effective’ for ARDS subgroup https://www.proactiveinvestors.com.au/companies/news/311455/faron-pharma-confident-traumakine-could-be-very-effective-for-ards-subgroup-11455.html Wed, 05 Dec 2018 13:37:00 +1100 https://www.proactiveinvestors.com.au/companies/news/311455/faron-pharma-confident-traumakine-could-be-very-effective-for-ards-subgroup-11455.html Faron convinced Traumakine still has potential as an ARDS treatment https://www.proactiveinvestors.com.au/companies/news/210549/faron-convinced-traumakine-still-has-potential-as-an-ards-treatment-210549.html Wed, 05 Dec 2018 07:41:00 +1100 https://www.proactiveinvestors.com.au/companies/news/210549/faron-convinced-traumakine-still-has-potential-as-an-ards-treatment-210549.html Faron Pharmaceuticals says Phase I/II study of novel precision cancer immunotherapy drug approved by Finnish Medicines Agency https://www.proactiveinvestors.com.au/companies/news/210368/faron-pharmaceuticals-says-phase-iii-study-of-novel-precision-cancer-immunotherapy-drug-approved-by-finnish-medicines-agency-210368.html Mon, 03 Dec 2018 08:18:00 +1100 https://www.proactiveinvestors.com.au/companies/news/210368/faron-pharmaceuticals-says-phase-iii-study-of-novel-precision-cancer-immunotherapy-drug-approved-by-finnish-medicines-agency-210368.html Follow up study points to 'even bigger opportunity' for Traumakine - Faron Pharma CEO https://www.proactiveinvestors.com.au/companies/news/311083/follow-up-study-points-to-even-bigger-opportunity-for-traumakine-faron-pharma-ceo-11083.html Thu, 01 Nov 2018 13:52:00 +1100 https://www.proactiveinvestors.com.au/companies/news/311083/follow-up-study-points-to-even-bigger-opportunity-for-traumakine-faron-pharma-ceo-11083.html Faron's follow-up investigations may breathe new life into Traumakine development https://www.proactiveinvestors.com.au/companies/news/207591/faron-s-follow-up-investigations-may-breathe-new-life-into-traumakine-development-207591.html Mon, 22 Oct 2018 15:08:00 +1100 https://www.proactiveinvestors.com.au/companies/news/207591/faron-s-follow-up-investigations-may-breathe-new-life-into-traumakine-development-207591.html Faron Pharma submits clinical trial application for its precision cancer immunotherapy https://www.proactiveinvestors.com.au/companies/news/204990/faron-pharma-submits-clinical-trial-application-for-its-precision-cancer-immunotherapy-204990.html Mon, 17 Sep 2018 12:48:00 +1000 https://www.proactiveinvestors.com.au/companies/news/204990/faron-pharma-submits-clinical-trial-application-for-its-precision-cancer-immunotherapy-204990.html Faron Pharma: Making sense of the recent news flow https://www.proactiveinvestors.com.au/companies/news/205030/faron-pharma-making-sense-of-the-recent-news-flow-205030.html Mon, 17 Sep 2018 12:23:00 +1000 https://www.proactiveinvestors.com.au/companies/news/205030/faron-pharma-making-sense-of-the-recent-news-flow-205030.html Faron Pharma to take Clevegen cancer candidate into the clinic this year https://www.proactiveinvestors.com.au/companies/news/310466/faron-pharma-to-take-clevegen-cancer-candidate-into-the-clinic-this-year-10466.html Thu, 13 Sep 2018 14:51:00 +1000 https://www.proactiveinvestors.com.au/companies/news/310466/faron-pharma-to-take-clevegen-cancer-candidate-into-the-clinic-this-year-10466.html Faron Pharma boss “excited” to begin first in-human trial of Clevegen later this year https://www.proactiveinvestors.com.au/companies/news/204832/faron-pharma-boss-excited-to-begin-first-in-human-trial-of-clevegen-later-this-year-204832.html Thu, 13 Sep 2018 10:56:00 +1000 https://www.proactiveinvestors.com.au/companies/news/204832/faron-pharma-boss-excited-to-begin-first-in-human-trial-of-clevegen-later-this-year-204832.html Faron Pharma says evidence base building around its technology https://www.proactiveinvestors.com.au/companies/news/204745/faron-pharma-says-evidence-base-building-around-its-technology-204745.html Wed, 12 Sep 2018 13:12:00 +1000 https://www.proactiveinvestors.com.au/companies/news/204745/faron-pharma-says-evidence-base-building-around-its-technology-204745.html Faron Pharma welcomes latest Clever-1 data https://www.proactiveinvestors.com.au/companies/news/204704/faron-pharma-welcomes-latest-clever-1-data-204704.html Wed, 12 Sep 2018 06:31:00 +1000 https://www.proactiveinvestors.com.au/companies/news/204704/faron-pharma-welcomes-latest-clever-1-data-204704.html Faron Pharmaceuticals looks to Clevegen opportunity after Traumakine disappointment https://www.proactiveinvestors.com.au/companies/news/190561/faron-pharmaceuticals-looks-to-clevegen-opportunity-after-traumakine-disappointment-190561.html Thu, 09 Aug 2018 08:00:00 +1000 https://www.proactiveinvestors.com.au/companies/news/190561/faron-pharmaceuticals-looks-to-clevegen-opportunity-after-traumakine-disappointment-190561.html Faron Pharmaceuticals to file clinical trial application for Clevegen after successful study https://www.proactiveinvestors.com.au/companies/news/199749/faron-pharmaceuticals-to-file-clinical-trial-application-for-clevegen-after-successful-study-199749.html Thu, 28 Jun 2018 06:31:00 +1000 https://www.proactiveinvestors.com.au/companies/news/199749/faron-pharmaceuticals-to-file-clinical-trial-application-for-clevegen-after-successful-study-199749.html Faron Pharmaceuticals garners some encouragement from phase III data; still searching for answers to key questions https://www.proactiveinvestors.com.au/companies/news/198843/faron-pharmaceuticals-garners-some-encouragement-from-phase-iii-data-still-searching-for-answers-to-key-questions-198843.html Thu, 14 Jun 2018 06:34:00 +1000 https://www.proactiveinvestors.com.au/companies/news/198843/faron-pharmaceuticals-garners-some-encouragement-from-phase-iii-data-still-searching-for-answers-to-key-questions-198843.html Faron Pharmaceuticals gains some early understanding of phase III trial data https://www.proactiveinvestors.com.au/companies/news/196801/faron-pharmaceuticals-gains-some-early-understanding-of-phase-iii-trial-data-196801.html Fri, 11 May 2018 06:20:00 +1000 https://www.proactiveinvestors.com.au/companies/news/196801/faron-pharmaceuticals-gains-some-early-understanding-of-phase-iii-trial-data-196801.html Faron Pharma assesses options after phase III disappointment https://www.proactiveinvestors.com.au/companies/news/196516/faron-pharma-assesses-options-after-phase-iii-disappointment-196516.html Tue, 08 May 2018 06:32:00 +1000 https://www.proactiveinvestors.com.au/companies/news/196516/faron-pharma-assesses-options-after-phase-iii-disappointment-196516.html A 'thrilling' year ahead for Faron Pharmaceuticals with Phase III Traumakine results in Q2 https://www.proactiveinvestors.com.au/companies/news/308781/a-thrilling-year-ahead-for-faron-pharmaceuticals-with-phase-iii-traumakine-results-in-q2-8781.html Wed, 21 Feb 2018 12:14:00 +1100 https://www.proactiveinvestors.com.au/companies/news/308781/a-thrilling-year-ahead-for-faron-pharmaceuticals-with-phase-iii-traumakine-results-in-q2-8781.html Faron Pharmaceuticals raises £15mln to establish network for Traumakine launch https://www.proactiveinvestors.com.au/companies/news/191754/faron-pharmaceuticals-raises-15mln-to-establish-network-for-traumakine-launch-191754.html Fri, 16 Feb 2018 16:00:00 +1100 https://www.proactiveinvestors.com.au/companies/news/191754/faron-pharmaceuticals-raises-15mln-to-establish-network-for-traumakine-launch-191754.html Faron establishes second Traumakine manufacturing site as it prepares for commercialisation https://www.proactiveinvestors.com.au/companies/news/191126/faron-establishes-second-traumakine-manufacturing-site-as-it-prepares-for-commercialisation-191126.html Mon, 05 Feb 2018 07:39:00 +1100 https://www.proactiveinvestors.com.au/companies/news/191126/faron-establishes-second-traumakine-manufacturing-site-as-it-prepares-for-commercialisation-191126.html Faron extends patent protection for Clevegen cancer immunotherapy https://www.proactiveinvestors.com.au/companies/news/190975/faron-extends-patent-protection-for-clevegen-cancer-immunotherapy-190975.html Thu, 01 Feb 2018 15:00:00 +1100 https://www.proactiveinvestors.com.au/companies/news/190975/faron-extends-patent-protection-for-clevegen-cancer-immunotherapy-190975.html Faron Pharmaceuticals drug receives fast-track designation from US regulator https://www.proactiveinvestors.com.au/companies/news/190737/faron-pharmaceuticals-drug-receives-fast-track-designation-from-us-regulator-190737.html Mon, 29 Jan 2018 12:15:00 +1100 https://www.proactiveinvestors.com.au/companies/news/190737/faron-pharmaceuticals-drug-receives-fast-track-designation-from-us-regulator-190737.html Faron Pharmaceuticals makes more headway with the US regulator https://www.proactiveinvestors.com.au/companies/news/190517/faron-pharmaceuticals-makes-more-headway-with-the-us-regulator-190517.html Wed, 24 Jan 2018 16:07:00 +1100 https://www.proactiveinvestors.com.au/companies/news/190517/faron-pharmaceuticals-makes-more-headway-with-the-us-regulator-190517.html Faron Pharmaceuticals receives clinical trial green light in second indication for lead drug https://www.proactiveinvestors.com.au/companies/news/188991/faron-pharmaceuticals-receives-clinical-trial-green-light-in-second-indication-for-lead-drug-188991.html Tue, 19 Dec 2017 07:32:00 +1100 https://www.proactiveinvestors.com.au/companies/news/188991/faron-pharmaceuticals-receives-clinical-trial-green-light-in-second-indication-for-lead-drug-188991.html Faron Pharmaceuticals completes recruitment for phase III trials of its ARDS treatment https://www.proactiveinvestors.com.au/companies/news/188573/faron-pharmaceuticals-completes-recruitment-for-phase-iii-trials-of-its-ards-treatment-188573.html Mon, 11 Dec 2017 09:17:00 +1100 https://www.proactiveinvestors.com.au/companies/news/188573/faron-pharmaceuticals-completes-recruitment-for-phase-iii-trials-of-its-ards-treatment-188573.html Faron Pharmaceuticals hires chief commercial officer ahead of drug launch https://www.proactiveinvestors.com.au/companies/news/188104/faron-pharmaceuticals-hires-chief-commercial-officer-ahead-of-drug-launch-188104.html Fri, 01 Dec 2017 07:54:00 +1100 https://www.proactiveinvestors.com.au/companies/news/188104/faron-pharmaceuticals-hires-chief-commercial-officer-ahead-of-drug-launch-188104.html Faron Pharmaceuticals' £10mln fundraiser will accelerate progress https://www.proactiveinvestors.com.au/companies/news/185103/faron-pharmaceuticals-10mln-fundraiser-will-accelerate-progress-185103.html Thu, 05 Oct 2017 07:24:00 +1100 https://www.proactiveinvestors.com.au/companies/news/185103/faron-pharmaceuticals-10mln-fundraiser-will-accelerate-progress-185103.html Faron Pharmaceuticals' lead drug gets significant vote of confidence from UK regulator https://www.proactiveinvestors.com.au/companies/news/184887/faron-pharmaceuticals-lead-drug-gets-significant-vote-of-confidence-from-uk-regulator-184887.html Mon, 02 Oct 2017 13:00:00 +1100 https://www.proactiveinvestors.com.au/companies/news/184887/faron-pharmaceuticals-lead-drug-gets-significant-vote-of-confidence-from-uk-regulator-184887.html Faron Pharma primed for a pivotal period in its development https://www.proactiveinvestors.com.au/companies/news/183509/faron-pharma-primed-for-a-pivotal-period-in-its-development-183509.html Wed, 06 Sep 2017 13:50:00 +1000 https://www.proactiveinvestors.com.au/companies/news/183509/faron-pharma-primed-for-a-pivotal-period-in-its-development-183509.html Faron Pharmaceuticals boss upbeat as Phase III trial enters critical period https://www.proactiveinvestors.com.au/companies/news/308040/faron-pharmaceuticals-boss-upbeat-as-phase-iii-trial-enters-critical-period-8040.html Wed, 06 Sep 2017 11:54:00 +1000 https://www.proactiveinvestors.com.au/companies/news/308040/faron-pharmaceuticals-boss-upbeat-as-phase-iii-trial-enters-critical-period-8040.html Faron Pharma gets a boost as FDA says can use outside US trial data for Traumakine license application https://www.proactiveinvestors.com.au/companies/news/183382/faron-pharma-gets-a-boost-as-fda-says-can-use-outside-us-trial-data-for-traumakine-license-application-183382.html Mon, 04 Sep 2017 09:58:00 +1000 https://www.proactiveinvestors.com.au/companies/news/183382/faron-pharma-gets-a-boost-as-fda-says-can-use-outside-us-trial-data-for-traumakine-license-application-183382.html Faron Pharma to provide drug compassionate use of drug; data monitors green light study as it moves into its final few months https://www.proactiveinvestors.com.au/companies/news/181968/faron-pharma-to-provide-drug-compassionate-use-of-drug-data-monitors-green-light-study-as-it-moves-into-its-final-few-months-181968.html Fri, 04 Aug 2017 06:27:00 +1000 https://www.proactiveinvestors.com.au/companies/news/181968/faron-pharma-to-provide-drug-compassionate-use-of-drug-data-monitors-green-light-study-as-it-moves-into-its-final-few-months-181968.html Faron Pharmacueticals' Traumakine study making good progress https://www.proactiveinvestors.com.au/companies/news/177428/faron-pharmacueticals-traumakine-study-making-good-progress-177428.html Mon, 08 May 2017 13:31:00 +1000 https://www.proactiveinvestors.com.au/companies/news/177428/faron-pharmacueticals-traumakine-study-making-good-progress-177428.html Drug developer Faron Pharmaceuticals to appoint two industry heavyweights to the board https://www.proactiveinvestors.com.au/companies/news/176574/drug-developer-faron-pharmaceuticals-to-appoint-two-industry-heavyweights-to-the-board-176574.html Wed, 19 Apr 2017 07:03:00 +1000 https://www.proactiveinvestors.com.au/companies/news/176574/drug-developer-faron-pharmaceuticals-to-appoint-two-industry-heavyweights-to-the-board-176574.html Faron Pharmaceuticals' Markku Jalkanen 'excited' to be advancing Clevegen https://www.proactiveinvestors.com.au/companies/news/307292/faron-pharmaceuticals-markku-jalkanen-excited-to-be-advancing-clevegen-7292.html Tue, 18 Apr 2017 12:22:00 +1000 https://www.proactiveinvestors.com.au/companies/news/307292/faron-pharmaceuticals-markku-jalkanen-excited-to-be-advancing-clevegen-7292.html Faron teams up with University of Birmingham for Clevegen liver cancer clinical program https://www.proactiveinvestors.com.au/companies/news/176512/faron-teams-up-with-university-of-birmingham-for-clevegen-liver-cancer-clinical-program-176512.html Tue, 18 Apr 2017 07:14:00 +1000 https://www.proactiveinvestors.com.au/companies/news/176512/faron-teams-up-with-university-of-birmingham-for-clevegen-liver-cancer-clinical-program-176512.html 'This year will give us the results we've been waiting for', says Faron pharmaceuticals boss https://www.proactiveinvestors.com.au/companies/news/307186/-this-year-will-give-us-the-results-we-ve-been-waiting-for-says-faron-pharmaceuticals-boss-7186.html Wed, 29 Mar 2017 14:59:00 +1100 https://www.proactiveinvestors.com.au/companies/news/307186/-this-year-will-give-us-the-results-we-ve-been-waiting-for-says-faron-pharmaceuticals-boss-7186.html Drug developer Faron Pharmaceuticals' annual results statement charts a year of major landmarks https://www.proactiveinvestors.com.au/companies/news/175583/drug-developer-faron-pharmaceuticals-annual-results-statement-charts-a-year-of-major-landmarks-175583.html Wed, 29 Mar 2017 06:35:00 +1100 https://www.proactiveinvestors.com.au/companies/news/175583/drug-developer-faron-pharmaceuticals-annual-results-statement-charts-a-year-of-major-landmarks-175583.html Faron Pharmaceuticals raises £5mln in premium placing https://www.proactiveinvestors.com.au/companies/news/173893/faron-pharmaceuticals-raises-5mln-in-premium-placing-173893.html Wed, 01 Mar 2017 15:15:00 +1100 https://www.proactiveinvestors.com.au/companies/news/173893/faron-pharmaceuticals-raises-5mln-in-premium-placing-173893.html Faron Pharmaceuticals drug Traumakine goes into phase II clinical trials for second major indication https://www.proactiveinvestors.com.au/companies/news/173372/faron-pharmaceuticals-drug-traumakine-goes-into-phase-ii-clinical-trials-for-second-major-indication-173372.html Mon, 20 Feb 2017 14:03:00 +1100 https://www.proactiveinvestors.com.au/companies/news/173372/faron-pharmaceuticals-drug-traumakine-goes-into-phase-ii-clinical-trials-for-second-major-indication-173372.html Faron Pharmaceuticals to build on success of 'extremely exciting' 2016 https://www.proactiveinvestors.com.au/companies/news/306892/faron-pharmaceuticals-to-build-on-success-of-extremely-exciting-2016-6892.html Thu, 09 Feb 2017 11:36:00 +1100 https://www.proactiveinvestors.com.au/companies/news/306892/faron-pharmaceuticals-to-build-on-success-of-extremely-exciting-2016-6892.html Faron Pharmaceuticals 'excited' about key year as it gears up for successful completion of clinical trial https://www.proactiveinvestors.com.au/companies/news/172909/faron-pharmaceuticals-excited-about-key-year-as-it-gears-up-for-successful-completion-of-clinical-trial-172909.html Thu, 09 Feb 2017 08:15:00 +1100 https://www.proactiveinvestors.com.au/companies/news/172909/faron-pharmaceuticals-excited-about-key-year-as-it-gears-up-for-successful-completion-of-clinical-trial-172909.html Faron Pharmaceuticals boss says patent protection is very significant step https://www.proactiveinvestors.com.au/companies/news/306292/faron-pharmaceuticals-boss-says-patent-protection-is-very-significant-step-6292.html Mon, 31 Oct 2016 13:23:00 +1100 https://www.proactiveinvestors.com.au/companies/news/306292/faron-pharmaceuticals-boss-says-patent-protection-is-very-significant-step-6292.html Faron has Finnish patent application accepted https://www.proactiveinvestors.com.au/companies/news/168244/faron-has-finnish-patent-application-accepted-168244.html Mon, 31 Oct 2016 07:41:00 +1100 https://www.proactiveinvestors.com.au/companies/news/168244/faron-has-finnish-patent-application-accepted-168244.html Recruitment starts in Japan for pivotal trial for Faron's Traumakine https://www.proactiveinvestors.com.au/companies/news/167813/recruitment-starts-in-japan-for-pivotal-trial-for-faron-s-traumakine-167813.html Mon, 24 Oct 2016 06:35:00 +1100 https://www.proactiveinvestors.com.au/companies/news/167813/recruitment-starts-in-japan-for-pivotal-trial-for-faron-s-traumakine-167813.html Faron Pharmaceuticals' Markku Jalkanen presents at the Biotech Capital Conference https://www.proactiveinvestors.com.au/companies/news/306141/faron-pharmaceuticals-markku-jalkanen-presents-at-the-biotech-capital-conference-6141.html Fri, 07 Oct 2016 13:59:00 +1100 https://www.proactiveinvestors.com.au/companies/news/306141/faron-pharmaceuticals-markku-jalkanen-presents-at-the-biotech-capital-conference-6141.html Faron Pharmaceuticals Oy’s options widen after fund-raising https://www.proactiveinvestors.com.au/companies/news/306060/faron-pharmaceuticals-oys-options-widen-after-fund-raising-6060.html Wed, 28 Sep 2016 10:01:00 +1000 https://www.proactiveinvestors.com.au/companies/news/306060/faron-pharmaceuticals-oys-options-widen-after-fund-raising-6060.html Faron sees healthy appetite for City fundraiser https://www.proactiveinvestors.com.au/companies/news/166141/faron-sees-healthy-appetite-for-city-fundraiser-166141.html Tue, 20 Sep 2016 06:31:00 +1000 https://www.proactiveinvestors.com.au/companies/news/166141/faron-sees-healthy-appetite-for-city-fundraiser-166141.html Faron Pharmaceuticals Oy boss pleased with healthier than expected cash balance https://www.proactiveinvestors.com.au/companies/news/305814/faron-pharmaceuticals-oy-boss-pleased-with-healthier-than-expected-cash-balance-5814.html Tue, 06 Sep 2016 14:25:00 +1000 https://www.proactiveinvestors.com.au/companies/news/305814/faron-pharmaceuticals-oy-boss-pleased-with-healthier-than-expected-cash-balance-5814.html Faron Pharma's cash balance healthier than anticipated https://www.proactiveinvestors.com.au/companies/news/147685/faron-pharma-s-cash-balance-healthier-than-anticipated-147685.html Mon, 05 Sep 2016 06:55:00 +1000 https://www.proactiveinvestors.com.au/companies/news/147685/faron-pharma-s-cash-balance-healthier-than-anticipated-147685.html Faron and Abzena agree manufacturing deal https://www.proactiveinvestors.com.au/companies/news/128555/faron-and-abzena-agree-manufacturing-deal-128555.html Mon, 25 Jul 2016 06:56:00 +1000 https://www.proactiveinvestors.com.au/companies/news/128555/faron-and-abzena-agree-manufacturing-deal-128555.html Faron Pharmaceuticals drug has ‘tremendous potential’ following Korea deal, says CEO https://www.proactiveinvestors.com.au/companies/news/305200/faron-pharmaceuticals-drug-has-tremendous-potential-following-korea-deal-says-ceo-5200.html Wed, 29 Jun 2016 11:46:00 +1000 https://www.proactiveinvestors.com.au/companies/news/305200/faron-pharmaceuticals-drug-has-tremendous-potential-following-korea-deal-says-ceo-5200.html Faron sees broad market for cancer treatment https://www.proactiveinvestors.com.au/companies/news/127095/faron-sees-broad-market-for-cancer-treatment-127095.html Tue, 14 Jun 2016 08:58:00 +1000 https://www.proactiveinvestors.com.au/companies/news/127095/faron-sees-broad-market-for-cancer-treatment-127095.html Faron strikes Korea licensing deal for flagship drug https://www.proactiveinvestors.com.au/companies/news/127023/faron-strikes-korea-licensing-deal-for-flagship-drug-127023.html Mon, 13 Jun 2016 06:26:00 +1000 https://www.proactiveinvestors.com.au/companies/news/127023/faron-strikes-korea-licensing-deal-for-flagship-drug-127023.html Faron goes on the TIET offensive against cancer with new development https://www.proactiveinvestors.com.au/companies/news/126404/faron-goes-on-the-tiet-offensive-against-cancer-with-new-development-126404.html Thu, 26 May 2016 06:31:00 +1000 https://www.proactiveinvestors.com.au/companies/news/126404/faron-goes-on-the-tiet-offensive-against-cancer-with-new-development-126404.html Faron Pharmaceuticals appoints medical director as clinical activity expands https://www.proactiveinvestors.com.au/companies/news/125470/faron-pharmaceuticals-appoints-medical-director-as-clinical-activity-expands-125470.html Tue, 03 May 2016 07:00:00 +1000 https://www.proactiveinvestors.com.au/companies/news/125470/faron-pharmaceuticals-appoints-medical-director-as-clinical-activity-expands-125470.html Faron Pharma chief hopes for global patent protection for Clevegen https://www.proactiveinvestors.com.au/companies/news/304911/faron-pharma-chief-hopes-for-global-patent-protection-for-clevegen-4911.html Tue, 19 Apr 2016 10:03:00 +1000 https://www.proactiveinvestors.com.au/companies/news/304911/faron-pharma-chief-hopes-for-global-patent-protection-for-clevegen-4911.html Faron files patent application for cancer treatment https://www.proactiveinvestors.com.au/companies/news/124937/faron-files-patent-application-for-cancer-treatment-124937.html Tue, 19 Apr 2016 06:29:00 +1000 https://www.proactiveinvestors.com.au/companies/news/124937/faron-files-patent-application-for-cancer-treatment-124937.html Hopes rise for AIM drug breakthroughs https://www.proactiveinvestors.com.au/companies/news/124096/hopes-rise-for-aim-drug-breakthroughs-124096.html Sat, 26 Mar 2016 15:00:00 +1100 https://www.proactiveinvestors.com.au/companies/news/124096/hopes-rise-for-aim-drug-breakthroughs-124096.html Faron Pharmaceuticals hails a breakthrough year https://www.proactiveinvestors.com.au/companies/news/123506/faron-pharmaceuticals-hails-a-breakthrough-year-123506.html Thu, 10 Mar 2016 07:43:00 +1100 https://www.proactiveinvestors.com.au/companies/news/123506/faron-pharmaceuticals-hails-a-breakthrough-year-123506.html Faron Pharmaceuticals aiming to become the home run king https://www.proactiveinvestors.com.au/companies/news/123216/faron-pharmaceuticals-aiming-to-become-the-home-run-king-123216.html Wed, 17 Feb 2016 11:28:00 +1100 https://www.proactiveinvestors.com.au/companies/news/123216/faron-pharmaceuticals-aiming-to-become-the-home-run-king-123216.html Faron Pharmaceuticals boss talks Traumakine and recent listing on AIM https://www.proactiveinvestors.com.au/companies/news/304607/faron-pharmaceuticals-boss-talks-traumakine-and-recent-listing-on-aim-4607.html Wed, 03 Feb 2016 09:02:00 +1100 https://www.proactiveinvestors.com.au/companies/news/304607/faron-pharmaceuticals-boss-talks-traumakine-and-recent-listing-on-aim-4607.html Faron Pharma gets €1.5mln funding to develop cancer drug https://www.proactiveinvestors.com.au/companies/news/120694/faron-pharma-gets-15mln-funding-to-develop-cancer-drug-120694.html Mon, 21 Dec 2015 10:35:00 +1100 https://www.proactiveinvestors.com.au/companies/news/120694/faron-pharma-gets-15mln-funding-to-develop-cancer-drug-120694.html Faron Pharmaceuticals makes premium AIM debut https://www.proactiveinvestors.com.au/companies/news/119284/faron-pharmaceuticals-makes-premium-aim-debut-119284.html Tue, 17 Nov 2015 10:18:00 +1100 https://www.proactiveinvestors.com.au/companies/news/119284/faron-pharmaceuticals-makes-premium-aim-debut-119284.html